GlobalGenes, BIO Work Together to Present MIT H@cking Medicine June 26th
June 17, 2014
Ever had a really great brainstorming session?
When great minds work together, they can discover some pretty incredible things! That’s why Global Genes is so proud to be in a pioneering partnership with BIO for the 4-hour, Idea Hack, hosted by MIT H@cking Medicine, on Thursday, June 26 in conjunction with the 2014 BIO International Convention in San Diego, California.
“Rare disease communities have always gained strength by coming together to work for common goals,” said Wendy White, Founder and CEO of Siren Interactive. “But now we’re taking our model of collaboration to a new level. Our success at MIT’s H@cking Medicine shows how we can accelerate progress by expanding our partnerships to include healthcare organizations, universities, pharmaceutical and biotech companies, as well as patient organizations. There’s tremendous power in these collaborations because we all care about one thing: finding innovative solutions to help patients.”
This gathering of diverse perspectives will bring industry stakeholders, clinicians, entrepreneurs, and engineers together to tackle complex health challenges with the aim to innovate testable, fundable solutions. Stakeholders will present the challenges, and participants will help solve them. Among the exciting themes at this event:
- Patient-centric holistic solutions
- Patient-doctor-caregiver communication
- Scalable healthcare software and technology-enabled services
- Transparent collaborations with self-insured employers, provider networks, product companies
- Rapid pilots prototyped to generate data to prove and improve care
MIT Hacking Medicine was founded in 2011 to energize and connect the best minds across MIT and the health ecosystem to teach, learn, and launch disruptive healthcare solutions to solve healthcare’s biggest challenges at home and abroad.
“We have held 16 hackathons across 4 continents which has resulted in the participation of close to 2000 individuals and the development of nearly 300 teams and a couple dozen ventures,” said MIT’s Andrea Ippolito. “Hackathons allow for rapid innovation to energize and infect by validating needs early in the front end of innovation and by bringing together diverse stakeholders in healthcare, business, design, and engineering. Many of these ventures formed out of our hackathons have gone on to raise venture funds, pursue clinical trials, and impact patient care.”
To learn more please visit: https://convention.bio.org/hackathon/
Should I Participate?
In just two years, MIT’s H@cking Medicine hack-a-thons have spawned more than a dozen companies. H@cking Medicine has also previously run hack-a-thons for pharmaceutical executives, electronic consenting, software and hardware devices. Stakeholders leave with key insights and novel ideas on how to engage successfully in products and drug development in innovative ways.
Great “hacks” attract a mix of individuals including professionals with R&D, technology, investment, and engineering backgrounds. Don’t miss the opportunity to contribute ideas to a community of diverse and interested participants.
Sign up for updates straight to your inbox.